1.
Pancevski G, Pepic S, Idoska S, Tofoski G, Nikolovska S. Topical Imiquimod 5% as a Treatment Option in Solitary Facial Keratoacanthoma. Open Access Maced J Med Sci [Internet]. 2018 Mar. 8 [cited 2024 May 4];6(3):531-5. Available from: https://oamjms.eu/index.php/mjms/article/view/oamjms.2018.133